News
Find out what’s hitting the headlines in our pioneering dementia research and how your support is bringing us closer to a cure.
If you have a press enquiry please visit our Press Office page.
- All
- Archive
- Celebrity news
- Fundraising news
- Policy news
- Science news
Local charitable trust invests £10m in dementia drug discovery
The ALBORADA Trust, based near Newmarket, has donated £5 million to Alzheimer’s Research UK, the UK’s leading dementia research charity.
Dementia research charity awards Cardiff scientists £387k to accelerate the search for a cure
Alzheimer’s Research UK, the UK’s leading dementia research charity, has funded two researchers from Cardiff University to carry out projects aimed at finding new treatments for Alzheimer’s disease.
Chair of Oldham Athletic travels to Essex to train for 3,000-mile charity row across the Atlantic
This December, Oldham Athletic owner, and adventurer, Frank Rothwell, 73, will row 3,000-miles across the Atlantic, with the aim of raising £1 million for Alzheimer’s Research UK.
Ted Lasso actor Kola Bokinni reveals dad has dementia, as he supports powerful new campaign from Alzheimer’s Research UK
Ted Lasso star Kola Bokinni has publicly shared for the first time the devastating impact dementia has had on his family to drive awareness and support Alzheimer’s Research UK’s search for a cure.
Olivia Colman backs new campaign, as charity reveals 1 in 2 people don’t know dementia causes memory loss
Despite almost one million people in the UK living with dementia today, and it being the UK’s leading cause of death, there is still a widespread lack of awareness around the impact it has on people affected by the condition. Alzheimer’s Research UK’s launches new campaign film to change this.
New report calls for manifesto pledges to tackle ‘completely unacceptable’ diagnosis rates
Ahead of the next general election campaign, Alzheimer’s Research UK has set out a series of calls for party leaders to tackle the increasing pressure that dementia places on society, the NHS, and the economy.
Oldham Athletic chair, 73, to row across Atlantic Ocean to raise funds for Alzheimer’s Research UK
This December, Chair of Oldham Athletic A.F.C, Frank Rothwell, will race solo and unsupported across the Atlantic as part of the World’s Toughest Row.
Exposure to air pollution linked to increased use of psychiatric services by people with dementia
Researchers at King’s College London have found that exposure to air pollution is associated with an increase in use of mental health services by people with dementia.
Dementia research charity awards Exeter scientists £370k to accelerate progress for a cure
Alzheimer’s Research UK, the UK’s leading dementia research charity, has funded three researchers from the University of Exeter to carry out projects aimed at finding new treatments, boosting early diagnosis, and understanding the disease’s causes.
“Another milestone” – successful phase 3 trial of Alzheimer’s drug, donanemab, confirmed
Promising preliminary results from a trial of the Alzheimer’s drug donanemab, first announced in May, have now been confirmed.
New evidence linking sight loss to dementia
A new study suggests that sight loss in people over 71 years old may be linked to dementia. The study was published today (Thursday 13th July 2023) in the Journal of the American Medical Association (JAMA) Ophthalmology.
US regulator expands access to Alzheimer’s drug lecanemab
The US Food and Drug Administration (FDA) has granted full approval to the drug lecanemab (known commercially as Leqembi) for people in the US with confirmed amyloid positivity and a diagnosis of mild cognitive impairment (MCI) or early-stage Alzheimer’s disease.
Alzheimer’s Research UK supporter Fiona Phillips diagnosed with Alzheimer’s disease
TV presenter and Alzheimer’s Research UK supporter Fiona Phillips has been diagnosed with young onset Alzheimer’s disease.
Potential link between hormone replacement therapy and increased risk of dementia in later life
A large, observational Danish study has reported that menopausal women who use hormone replacement therapy (HRT) have an increased the risk of developing dementia in later life.
Footballer Gordon McQueen dies of vascular dementia
Former Leeds United, Manchester United and Scotland defender Gordon McQueen has died, aged 70.
Charities pledge half a million pounds to better understand the link between air pollution and dementia
This Clean Air Day, with teamed up with Race Against Dementia to award Dr Jake Brooks half a million pounds to help unravel how certain air pollution particles enter the brain and cause Alzheimer’s disease.
Coronation Street actor Julie Goodyear has dementia
Coronation Street star Julie Goodyear is living with dementia, her husband has announced today. Dementia is the leading cause of death in the UK, affecting almost one million people in the UK today. There are currently no treatments available to slow, stop or prevent the diseases, most commonly Alzheimer’s, that cause it. Alzheimer’s Research UK…
Alzheimer’s Research UK launches new flagship walking event
Alzheimer’s Research UK, the UK’s leading dementia research charity, is launching a new flagship walking event in three locations this summer.
Lower intake of flavanols linked to age-related memory loss, suggests new study
People who consume fewer plant-based chemical substances, called flavanols, as part of their diet may be more likely to experience age-related memory decline, suggests a new study.
Will Poulter narrates popular children’s book, Elmer and the Gift, in support of Alzheimer’s Research UK
To mark Dementia Action Week (15 – 21 May) and the release of the paperback, Will Poulter, star of Marvel’s Guardians of the Galaxy 3, will show his support for dementia research by narrating Elmer and the Gift, the final book in the popular series written and illustrated by the late David McKee.
Charities awarded £5m to revolutionise dementia diagnosis
Alzheimer’s Research UK and Alzheimer’s Society have been selected as the recipients of this year’s People’s Postcode Lottery (PPL) Dream Fund, worth £5m.
Second Alzheimer’s drug, donanemab, succeeds in Phase 3 trial
Today, the pharmaceutical company Eli Lilly announced that their Alzheimer’s drug, donanemab, has successfully slowed memory and thinking decline in a rigorous phase 3 trial. The TRAILBLAZER ALZ-2 trial tested the drug in nearly 1,200 people with early-stage Alzheimer’s disease. The announcement makes this the second drug to show positive results in the last six…
Dementia leading cause of death in 2022
The Office for National Statistics has revealed ‘dementia and Alzheimer’s disease’ were the leading cause of death in 2022.
Deep-brain stimulation restores memory in mice with Alzheimer’s symptoms
Scientists in the US have found that stimulating precise areas in the brains of mice can help alleviate Alzheimer’s symptoms.
Alzheimer’s Research UK Chief Executive named Co-Chair of national mission to tackle dementia
The UK Government has appointed Hilary Evans and Prof Nadeem Sarwar as Co-Chairs of the Dame Barbara Windsor Dementia Mission.
